EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 95 filers reported holding EDGEWISE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,014,775 | +55.2% | 1,049,699 | +109.9% | 0.04% | +59.1% |
| Q2 2023 | $3,875,000 | +16.2% | 500,000 | 0.0% | 0.02% | +22.2% |
| Q1 2023 | $3,335,000 | -25.4% | 500,000 | 0.0% | 0.02% | -33.3% |
| Q4 2022 | $4,470,000 | -9.1% | 500,000 | 0.0% | 0.03% | -15.6% |
| Q3 2022 | $4,920,000 | +23.6% | 500,000 | 0.0% | 0.03% | +39.1% |
| Q2 2022 | $3,980,000 | -17.9% | 500,000 | 0.0% | 0.02% | -17.9% |
| Q1 2022 | $4,850,000 | -36.5% | 500,000 | 0.0% | 0.03% | -24.3% |
| Q4 2021 | $7,640,000 | -8.0% | 500,000 | 0.0% | 0.04% | +2.8% |
| Q3 2021 | $8,300,000 | -22.2% | 500,000 | 0.0% | 0.04% | -23.4% |
| Q2 2021 | $10,665,000 | -34.4% | 500,000 | 0.0% | 0.05% | -32.9% |
| Q1 2021 | $16,250,000 | – | 500,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $15,288,000 | 9.07% |
| Novo Holdings A/S | 6,071,703 | $59,746,000 | 2.85% |
| Orbimed Advisors | 14,567,176 | $143,341,000 | 2.66% |
| Opaleye Management Inc. | 635,000 | $6,248,000 | 2.58% |
| Cormorant Asset Management, LP | 3,051,989 | $30,032,000 | 2.10% |
| DAFNA Capital Management LLC | 781,112 | $7,686,000 | 2.07% |
| SEVEN GRAND MANAGERS, LLC | 60,000 | $590,000 | 1.93% |
| Deep Track Capital, LP | 3,374,394 | $33,204,000 | 1.52% |
| EcoR1 Capital, LLC | 3,493,194 | $34,373,000 | 1.02% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $38,702,000 | 0.77% |